FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Deutsche Boerse AG 03:50:29 2024-05-17 pm EDT | ||
| 10.7 EUR | +1.90% |
|
| Current month | +3.14% | ||
| 1 month | +18.91% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 10.7 | +1.90% |
| 24-05-16 | 10.5 | +2.84% |
| 24-05-15 | 10.21 | +1.79% |
| 24-05-14 | 10.03 | -2.53% |
| 24-05-13 | 10.29 | +2.18% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PG2QDG |
| ISIN | DE000PG2QDG7 |
| Date issued | 2023-11-07 |
| Strike | 142.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.84 € |
|---|---|
| Lowest since issue | 7.71 € |
| Spread | 0.21 € |
| Spread % | 1.91% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
144.3
USD
Average target price
146.8
USD
Spread / Average Target
+1.70%
- Stock Market
- Certificates
- Certificat
